Now showing items 1-1 of 1

    • Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings 

      Gungor, B.; Yagci, F. C.; Gursel, I.; Gursel, M. (Taylor & Francis Inc., 2014-07)
      Type I interferon inducers may potentially be engineered to function as antiviral and anticancer agents, or alternatively, vaccine adjuvants, all of which may have clinical applications. We recently described a simple ...